Skip to main navigation Skip to search Skip to main content

Standards and standardization in mastocytosis: Consensus statements on diagnostics, treatment recommendations and response criteria

  • P. Valent
  • , C. Akin
  • , L. Escribano
  • , M. Födinger
  • , K. Hartmann
  • , K. Brockow
  • , M. Castells
  • , W. R. Sperr
  • , H. C. Kluin-Nelemans
  • , N. A.T. Hamdy
  • , O. Lortholary
  • , J. Robyn
  • , J. Van Doormaal
  • , K. Sotlar
  • , A. W. Hauswirth
  • , M. Arock
  • , O. Hermine
  • , A. Hellmann
  • , M. Triggiani
  • , M. Niedoszytko
  • L. B. Schwartz, A. Orfao, H. P. Horny, D. D. Metcalfe
  • Medical University of Vienna
  • University of Michigan Medical School
  • Neurología)
  • University of Cologne
  • Harvard Medical School
  • University Medical Center Groningen
  • Leiden University Medical Centre
  • Univ-Paris Diderot Sorbonne Paris-Cité
  • National Heart, Lung, and Blood Institute (NHLBI)
  • University of Tübingen
  • Ecole Normale Supérieure de Cachan
  • Hôpital Necker Enfants Malades
  • Medical Unversity of Gdansk
  • Università di Napoli Federico II
  • Virginia Commonwealth University
  • Universidad de Salamanca
  • Universidad de Salamanca
  • Universitätsklinikum Schleswig-Holstein Campus Lübeck
  • National Institute of Allergy and Infectious Diseases (NIAID)

Research output: Contribution to journalReview articlepeer-review

724 Scopus citations

Abstract

Although a classification for mastocytosis and diagnostic criteria are available, there remains a need to define standards for the application of diagnostic tests, clinical evaluations, and treatment responses. To address these demands, leading experts discussed current issues and standards in mastocytosis in a Working Conference. The present article provides the resulting outcome with consensus statements, which focus on the appropriate application of clinical and laboratory tests, patient selection for interventional therapy, and the selection of appropriate drugs. In addition, treatment response criteria for the various clinical conditions, disease-specific symptoms, and specific pathologies are provided. Resulting recommendations and algorithms should greatly facilitate the management of patients with mastocytosis in clinical practice, selection of patients for therapies, and the conduct of clinical trials.

Original languageEnglish
Pages (from-to)435-453
Number of pages19
JournalEuropean Journal of Clinical Investigation
Volume37
Issue number6
DOIs
StatePublished - Jun 2007

Keywords

  • Criteria
  • Mastocytosis
  • Patient selection
  • Standardization
  • Targeted drugs

Fingerprint

Dive into the research topics of 'Standards and standardization in mastocytosis: Consensus statements on diagnostics, treatment recommendations and response criteria'. Together they form a unique fingerprint.

Cite this